0       0

Long Term Care Medicine-2011


C40b - General Session II: Long Term Care Prescribing of Controlled Substances in the New Regulatory Environment


Mar 26, 2011 8:00am ‐ Mar 26, 2011 10:30am

Standard: $24.00

Description

Accreditation
The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement:
The American Medical Directors Association designates
this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMDCP Credit Designation:
This session has been approved for a total of 0.5 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).

Session Description:
A panel of presenters will describe recent enforcement and e-prescribing issues. They will offer practical ways to prescribe in the long term care setting, including the appropriate use of antipyschotics.

Learning Objectives(s):

  • Discuss AMDA's advocacy on the Controlled Substances Act and e-prescribing issues.
  • Offer practical ways to prescribe in the long term care setting.

Speakers(s):
Jonathan Musher, MD, CMD; David A. Brechtelsbauer, MD, CMD; Meenakshi Patel, MD, CMD; William Russell, MD

Disclosure(s):
David Brechtelsbauer, MD, CMD has no financial disclosures to report.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content